Search for: "LeBlanc v. Merrell Dow Pharmaceuticals, Inc." Results 1 - 5 of 5
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Pharmacists And The Learned Intermediary Rule
24 Feb 2011, 1:49 pm by Bexis
Richardson-Merrell, Inc., 643 F. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Exposure, Epidemiology, and External Validity under Rule 702
14 May 2012, 8:24 am by Schachtman
Perrier Group of America Inc., 986 F. [read post]
Tortini - http://schachtmanlaw.com/blog/
New Decisions Raise Old Issues
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
Daubert’s Error Rate
16 Jun 2015, 7:22 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 593 (1993) (specifying the “the known or potential rate of error” as one of several factors in assessing the scientific reliability or validity of proffered expert witness’s opinion) Kumho Tire Co. v. [read post]
Tortini - http://schachtmanlaw.com/blog/
Confounded by Confounding in Unexpected Places
12 Dec 2021, 2:22 pm by admin
Whitehall Labs., Inc., 874 F. [read post]
Tortini - http://schachtmanlaw.com/blog/